Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

nirogacestat hydrobromide

(NY-roh-GAY-seh-stat HY-droh-BROH-mide)
A drug used to treat adults with desmoid tumors (a type of soft tissue tumor) that have gotten worse and need systemic therapy. It is also being studied in the treatment of other types of cancer. Nirogacestat hydrobromide binds to a protein called gamma secretase, which blocks the activation of other proteins called Notch receptors. Blocking these proteins may help keep tumor cells from growing and may kill them. Nirogacestat hydrobromide is a type of gamma secretase inhibitor. Also called Ogsiveo.
Search NCI's Dictionary of Cancer Terms